OPINION: The government has spent over a billion on a drug called Acthar and allegedly no one at the company even knows what it's actually made of. 5/7/2019 · Mallinckrodt's stock closed down 1 percent on Friday, in anticipation of the report being aired. But shares of the drug maker have since bounced back, closing up more than 6 percent Monday. The report comes ahead of an anticipated speech by President Donald Trump in which he is expected to outline new policies to deliver on his pledge to bring down drug prices. Thank you for supporting this Stocks News Feed. At no cost to you, we do make a small commission if you make a purchase through the above link.